Position in FLNA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$718
-$21,079 QoQ
Shares Held
425
-96.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in FLNA Over Time
Shares Held
Position Value (USD)
Derivatives in FLNA
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
0
PutValue
$48,720
PutShares
1,165
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,946,405,239 across 415 Biotechnology names. FLNA ranks #347 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in FLNA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $718 | 425 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $21,797 | 11,009 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $50,081 | 17,210 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $164,530 | 90,901 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $135,361 | 90,241 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $152,363 | 64,561 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $257,453 | 8,748 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $43,200 | 3,498 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $423,756 | 20,885 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $429,918 | 19,099 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $339,755 | 20,418 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $256,111 | 10,445 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $386,981 | 16,044 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $167,225 | 5,661 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $48,720 | 1,165 | Put | Defined | 2022-11-16 | |
| 2022-09-30 | $5,402,809 | 129,192 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $35,571 | 1,265 | Put | Defined | 2022-08-12 | |
| 2022-06-30 | $6,221,971 | 221,265 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $128,504 | 3,460 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $898,209 | 20,554 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $426,613 | 6,872 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $125,340 | 1,467 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $447,297 | 9,951 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $42,113 | 6,175 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $72,513 | 6,300 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $2,673 | 868 | Shares | Defined | 2020-08-06 | |
| No filing history on record for this holder in this stock. | ||||||